カテゴリー： Market Research Future, 世界, 医療/バイオ

薬局管理システムの世界市場（〜2030）

◆英語タイトル：Pharmacy Management System Market Forecast to 2030
	◆商品コード：MRF23AP049 ◆発行会社（リサーチ会社）：Market Research Future ◆発行日：2023年3月7日 ◆ページ数：110 ◆レポート形式：英語 / PDF ◆納品方法：Eメール ◆調査対象地域：グローバル ◆産業分野：医療

◆販売価格オプション（消費税別）

Single User（印刷不可、Online Access）	USD4,950 ⇒換算￥752,400	見積依頼/購入/質問フォーム
Enterprisewide Price（印刷可）	USD7,250 ⇒換算￥1,102,000	見積依頼/購入/質問フォーム

★Market Research Futureに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

マーケットリサーチフューチャー社の市場調査では、世界の薬局管理システム市場規模が2030年までにCAGR 10.12％増加すると予測しています。本書では、薬局管理システムの世界市場について広く調査・分析をし、エグゼクティブサマリー、イントロダクション、調査手法、市場動向、市場要因分析、ソリューション種類別（薬局在庫管理システム、薬局データ管理システム、薬局調剤ソフトシステム、薬局利益管理システム、その他）分析、コンポーネント別（ソフトウェア、ハードウェア、サービス）分析、展開形態別（クラウド/ウェブ型、オンプレミス型）分析、エンドユーザー別（入院患者用薬局、外来用薬局）分析、地域別（北米、ヨーロッパ、アジア太平洋、中東・アフリカ）分析、競争状況、企業情報などを整理しました。なお、記載されている企業情報には、Allscripts Healthcare、LLC (US)、Cerner Corporation (US)、DataScan Pharmacy (US)、Epicor Software Corporation (US) GlobeMed Group (Lebanon)、Liberty Software,Ltd (US)、LS Retail EHF (Iceland)、McKesson Corporation (US)などが含まれています。
・エグゼクティブサマリー
・イントロダクション
・調査手法
・市場動向
・市場要因分析
・世界の薬局管理システム市場規模：ソリューション種類別
- 薬局在庫管理システムの市場規模
- 薬局データ管理システムの市場規模
- 薬局調剤ソフトシステムの市場規模
- 薬局利益管理システムの市場規模
- その他薬局管理システムの市場規模
・世界の薬局管理システム市場規模：コンポーネント別
- ソフトウェアの市場規模
- ハードウェアの市場規模
- サービスの市場規模
・世界の薬局管理システム市場規模：展開形態別
- クラウド/ウェブ型薬局管理システムの市場規模
- オンプレミス型薬局管理システムの市場規模
・世界の薬局管理システム市場規模：エンドユーザー別
- 入院患者用薬局における市場規模
- 外来用薬局における市場規模
・世界の薬局管理システム市場規模：地域別
- 北米の薬局管理システム市場規模
- ヨーロッパの薬局管理システム市場規模
- アジア太平洋の薬局管理システム市場規模
- 中東・アフリカの薬局管理システム市場規模
・競争状況
・企業情報

薬局管理システムの2030年までの市場予測

市場ダイナミクス：
薬局管理システム市場は、2030年までに10.12%の健全なCAGRを記録する見込みです。薬局の業務プロセスをコンピュータ化するために薬局で利用されるシステムは、薬局管理プログラミングとして知られています。これは、医師の薬を評価し、薬を準備し、在庫管理を組み込みます。薬局管理システムの世界的な市場開発は、重要なドライブの数の上昇、薬局管理システムに関連する利点、および治療薬の数の上昇のため、薬剤の専門家の重みに起因しています。また、新興国における薬局管理システムへの関心の高まりは、今後の市場に学習経験を与えます。しかし、例えば、ベンダーのセキュリティのような複雑なハイライトは、予測期間中に市場の発展を妨げる可能性があります。
薬局管理システムは、在庫管理、処方箋の管理、および取引機能などの割り当てを監督するために薬剤の専門家を支援する非常に強力でユーザーフレンドリーな管理利点を持つ巨大なデバイスです。これらのシステムはさらに、薬剤専門家が患者の必要性に照らして熟練した配慮を提供することを可能にします。派遣、統合や買収、協調的な取り組み、共同努力など、重要なドライブの数が増加しており、薬局管理システム市場を牽引しています。

セグメント概要：
ソリューションタイプ別では、薬局在庫管理ソフトウェア、薬局情報管理システム、薬局強化ソフトウェアシステム、薬局アドバンテージ管理、薬局収入サイクル管理システム、その他に区分されます。
コンポーネント別では、市場はソフトウェア、ハードウェア、サービスに分けられます。展開モード別では、市場はオンプレミスとクラウド/電子に二分されます。エンドユーザー別では、世界市場は継続的なドラッグストアと短期的なドラッグストアに二分されます。短期市場はさらに、クイックトラックセンターと救急クリニックの小売設定に細分化されます。

地域分析：
南北アメリカは、2030年末までに10.29%の大幅なCAGRを記録する見込みです。これは、例えば、バーンスルーの減少を支援し、スタッフの時間などを節約する機械化された終了日のフォローなど、機械的な前進の拡大に信用されています。アメリカの臨床薬学大学院によると、2021年までに約50億の治療薬が割り当てられ、薬の専門家の体重が増加します。
ヨーロッパ薬局管理システム市場は、フランス、ドイツ、イギリス、スイス、オランダ、ベルギー、ロシア、スペイン、イタリア、オーストリア、ヨーロッパの残りの部分に分離されています。薬局管理によって提供される利点は、薬剤の専門家が右のPCまたは携帯電話から、有利かつ面倒なことなく薬を監督するために力を与えます。さらに、地域全体でのウェブ浸透率の上昇、医療行政のさらなるデジタル化の進展、教育を受けた薬剤専門家の数の増加が、市場発展をさらに後押ししています。

主要企業：
DataScan Pharmacy (US), Cerner Corporation (US), Allscripts Healthcare, LLC (US), Epicor Software Corporation (US) GlobeMed Group (Lebanon), LS Retail EHF (Iceland), McKesson Corporation (US), Liberty Software, Inc. (US), MedHOK, Inc. (US), Octal IT Solution LLP (India), ScriptPro LLC (US), Clanwilliam Health (Ireland), Safecare Technology (UAE), Mobile MedSoft (US), and Health Business Systems, Inc. (US).

❖ レポートの目次 ❖

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

2.1 DEFINITION

2.2 SCOPE OF THE STUDY

2.3 RESEARCH OBJECTIVE SYSTEM

2.4 MARKET STRUCTURE

2.5 ASSUMPTIONS & LIMITATIONS

3 RESEARCH METHODOLOGY

3.1 DATA MINING

3.2 SECONDARY RESEARCH

3.3 PRIMARY RESEARCH

3.4 BREAKDOWN OF PRIMARY RESPONDENTS

3.5 FORECASTING TECHNIQUES

3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION

3.6.1 BOTTOM-UP APPROACH

3.6.2 TOP-DOWN APPROACH

3.7 DATA TRIANGULATION

3.8 VALIDATION

4 MARKET DYNAMICS

4.1 OVERVIEW

4.2 DRIVERS

4.2.1 RISE IN THE NUMBER OF STRATEGIC INITIATIVES

4.2.2 BENEFITS ASSOCIATED WITH PHARMACY MANAGEMENT SYSTEMS

4.2.3 BURDEN ON PHARMACISTS DUE TO INCREASING NUMBER OF PRESCRIPTIONS

4.3 RESTRAINTS

4.3.1 COMPLEX FEATURES SUCH AS VENDOR LOCK-IN

4.4 OPPORTUNITIES

4.4.1 INCREASING DEMAND FOR PHARMACY MANAGEMENT SYSTEMS IN EMERGING ECONOMIES

4.5 CHALLENGES

4.5.1 UNAVAILABILITY OF TRAINED PROFESSIONALS

5 MARKET FACTOR ANALYSIS

5.1 VALUE CHAIN ANALYSIS

5.1.1 INPUTS

5.1.2 SOFTWARE DEVELOPMENT PROCESSES

5.1.3 OUTPUT

5.1.4 MARKETING AND DISTRIBUTION

5.1.5 POST-SELLING SERVICES

5.1.5.1 SOFTWARE MAINTENANCE SERVICES & AGREEMENTS

5.1.5.2 TRAINING & CERTIFICATIONS

5.1.5.3 SUPPORT: TECHNICAL & GRIEVANCE AID

5.2 PORTER’S FIVE FORCES MODEL

5.2.1 THREAT OF NEW ENTRANTS

5.2.2 BARGAINING POWER OF SUPPLIERS

5.2.3 THREAT OF SUBSTITUTES

5.2.4 BARGAINING POWER OF BUYERS

5.2.5 INTENSITY OF RIVALRY

5.3 IMPACT OF COVID-19 ON THE PHARMACY MANAGEMENT SYSTEM MARKET

6 GLOBAL PHARMACY MANAGEMENT SYSTEM MARKET, BY SOLUTION TYPE

6.1 OVERVIEW

6.2 PHARMACY INVENTORY MANAGEMENT SYSTEM

6.3 PHARMACY DATA MANAGEMENT SYSTEM

6.4 PHARMACY COMPOUNDING SOFTWARE SYSTEM

6.5 PHARMACY BENEFITS MANAGEMENT SYSTEM

6.6 PHARMACY REVENUE CYCLE MANAGEMENT SYSTEM

6.7 OTHERS

7 GLOBAL PHARMACY MANAGEMENT SYSTEM MARKET, BY COMPONENT

7.1 OVERVIEW

7.2 SOFTWARE

7.3 HARDWARE

7.4 SERVICES

8 GLOBAL PHARMACY MANAGEMENT SYSTEM MARKET, BY DEPLOYMENT MODE

8.1 OVERVIEW

8.2 CLOUD/WEB-BASED

8.3 ON-PREMISE

9 GLOBAL PHARMACY MANAGEMENT SYSTEM MARKET, BY END USER

9.1 OVERVIEW

9.2 INPATIENT PHARMACIES

9.3 OUTPATIENT PHARMACIES

10 PHARMACY MANAGEMENT SYSTEMS, BY REGION

10.1 OVERVIEW

10.2 AMERICAS

10.2.1 NORTH AMERICA

10.2.1.1 US

10.2.1.2 CANADA

10.3 EUROPE

10.3.1 WESTERN EUROPE

10.3.1.1 GERMANY

10.3.1.2 FRANCE

10.3.1.3 UK

10.3.1.4 ITALY

10.3.1.5 SPAIN

10.3.1.6 NETHERLANDS

10.3.1.7 SWITZERLAND

10.3.1.8 BELGIUM

10.3.1.9 AUSTRIA

10.3.1.10 REST OF WESTERN EUROPE

10.3.2 EASTERN EUROPE

10.4 ASIA-PACIFIC

10.4.1 JAPAN

10.4.2 CHINA

10.4.3 INDIA

10.4.4 AUSTRALIA

10.4.5 SOUTH KOREA

10.4.6 TAIWAN

10.4.7 NEW ZEALAND

10.4.8 THAILAND

10.4.9 PHILIPPINES

10.4.10 REST OF ASIA-PACIFIC

10.5 MIDDLE EAST & AFRICA

10.5.1 MIDDLE EAST

10.5.2 AFRICA

11 COMPETITIVE LANDSCAPE

11.6 KEY DEVELOPMENTS & GROWTH STRATEGIES

11.6.1 PRODUCT LAUNCH/PRODUCT APPROVAL

11.6.2 MERGER & ACQUISITIONS

11.6.3 AGREEMENT/MARKETING STRATEGIES

12 COMPANY PROFILES

12.1 ALLSCRIPTS HEALTHCARE, LLC

12.1.1 COMPANY OVERVIEW

12.1.2 FINANCIAL OVERVIEW

12.1.3 PRODUCTS OFFERED

12.1.4 KEY DEVELOPMENTS

12.1.5 SWOT ANALYSIS

12.1.6 KEY STRATEGIES

12.2 CERNER CORPORATION

12.2.1 COMPANY OVERVIEW

12.2.2 PRODUCTS OFFERED

12.2.3 PRODUCTS OFFERED

12.2.4 KEY DEVELOPMENTS

12.2.5 SWOT ANALYSIS

12.2.6 KEY STRATEGIES

12.3 DATASCAN PHARMACY

12.3.1 COMPANY OVERVIEW

12.3.2 FINANCIAL OVERVIEW

12.3.3 PRODUCTS OFFERED

12.3.4 KEY DEVELOPMENTS

12.3.5 KEY STRATEGIES

12.4 EPICOR SOFTWARE CORPORATION

12.4.1 COMPANY OVERVIEW

12.4.2 FINANCIAL OVERVIEW

12.4.3 PRODUCTS OFFERED

12.4.4 KEY DEVELOPMENTS

12.4.5 SWOT ANALYSIS

12.4.6 KEY STRATEGIES

12.5 GLOBEMED GROUP

12.5.1 COMPANY OVERVIEW

12.5.2 FINANCIAL OVERVIEW

12.5.3 PRODUCTS OFFERED

12.5.4 KEY DEVELOPMENTS

12.5.5 SWOT ANALYSIS

12.5.6 KEY STRATEGIES

12.6 LIBERTY SOFTWARE, INC.

12.6.1 COMPANY OVERVIEW

12.6.2 FINANCIAL OVERVIEW

12.6.3 PRODUCTS OFFERED

12.6.4 KEY DEVELOPMENTS

12.6.5 KEY STRATEGIES

12.7 LS RETAIL EHF

12.7.1 COMPANY OVERVIEW

12.7.2 FINANCIAL OVERVIEW

12.7.3 PRODUCTS OFFERED

12.7.4 KEY DEVELOPMENTS

12.7.5 KEY STRATEGIES

12.8 MCKESSON CORPORATION

12.8.1 COMPANY OVERVIEW

12.8.2 FINANCIAL OVERVIEW

12.8.3 PRODUCTS OFFERED

12.8.4 KEY DEVELOPMENTS

12.8.5 SWOT ANALYSIS

12.8.6 KEY STRATEGIES

12.9 MEDHOK, INC.

12.9.1 COMPANY OVERVIEW

12.9.2 FINANCIAL OVERVIEW

12.9.3 PRODUCTS OFFERED

12.9.4 KEY DEVELOPMENTS

12.9.5 KEY STRATEGIES

12.10 OCTAL IT SOLUTION LLP

12.10.1 COMPANY OVERVIEW

12.10.2 FINANCIAL OVERVIEW

12.10.3 PRODUCTS OFFERED

12.10.4 KEY DEVELOPMENTS

12.10.5 KEY STRATEGIES

12.11 SAFECARE TECHNOLOGY

12.11.1 COMPANY OVERVIEW

12.11.2 FINANCIAL OVERVIEW

12.11.3 PRODUCTS OFFERED

12.11.4 KEY DEVELOPMENTS

12.11.5 KEY STRATEGIES

12.12 SCRIPTPRO LLC

12.12.1 COMPANY OVERVIEW

12.12.2 FINANCIAL OVERVIEW

12.12.3 PRODUCTS OFFERED

12.12.4 KEY DEVELOPMENTS

12.12.5 KEY STRATEGIES

12.13 CLANWILLIAM HEALTH

12.13.1 COMPANY OVERVIEW

12.13.2 FINANCIAL OVERVIEW

12.13.3 PRODUCTS OFFERED

12.13.4 KEY DEVELOPMENTS

12.13.5 KEY STRATEGIES

12.14 MOBILE MEDSOFT

12.14.1 COMPANY OVERVIEW

12.14.2 FINANCIAL OVERVIEW

12.14.3 PRODUCTS OFFERED

12.14.4 KEY DEVELOPMENTS

12.14.5 KEY STRATEGIES

12.15 HEALTH BUSINESS SYSTEMS, INC.

12.15.1 COMPANY OVERVIEW

12.15.2 FINANCIAL OVERVIEW

12.15.3 PRODUCTS OFFERED

12.15.4 KEY DEVELOPMENTS

12.15.5 KEY STRATEGIES

13 APPENDIX

13.1 REFERENCES

13.2 RELATED REPORTS

LIST OF TABLES

TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS

TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS

TABLE 3 GLOBAL: PHARMACY MANAGEMENT SYSTEM MARKET, BY SOLUTION TYPE, 2018–2030 (USD MILLION)

TABLE 4 GLOBAL: PHARMACY MANAGEMENT SYSTEM MARKET, FOR PHARMACY INVENTORY MANAGEMENT SYSTEM, BY REGION, 2018–2030 (USD MILLION)

TABLE 5 GLOBAL: PHARMACY MANAGEMENT SYSTEM MARKET, FOR PHARMACY DATA MANAGEMENT SYSTEM, BY REGION, 2018–2030 (USD MILLION)

TABLE 6 GLOBAL: PHARMACY MANAGEMENT SYSTEM MARKET, FOR PHARMACY COMPOUNDING SOFTWARE SYSTEM, BY REGION, 2018–2030 (USD MILLION)

TABLE 7 GLOBAL: PHARMACY MANAGEMENT SYSTEM MARKET, FOR PHARMA PHARMACY BENEFITS MANAGEMENT SYSTEM, BY REGION, 2018–2030 (USD MILLION)

TABLE 8 GLOBAL: PHARMACY MANAGEMENT SYSTEM MARKET, FOR PHARMACY REVENUE CYCLE MANAGEMENT SYSTEM, BY REGION, 2018–2030 (USD MILLION)

TABLE 9 GLOBAL: PHARMACY MANAGEMENT SYSTEM MARKET, FOR OTHERS, BY REGION, 2018–2030 (USD MILLION)

TABLE 10 GLOBAL: PHARMACY MANAGEMENT SYSTEM MARKET, BY COMPONENT, 2018–2030 (USD MILLION)

TABLE 11 GLOBAL: PHARMACY MANAGEMENT SYSTEM MARKET, FOR SOFTWARE, BY REGION, 2018–2030 (USD MILLION)

TABLE 12 GLOBAL: PHARMACY MANAGEMENT SYSTEM MARKET, FOR HARDWARE, BY REGION, 2018–2030 (USD MILLION)

TABLE 13 GLOBAL: PHARMACY MANAGEMENT SYSTEM MARKET, FOR SERVICES, BY REGION, 2018–2030 (USD MILLION)

TABLE 14 GLOBAL: PHARMACY MANAGEMENT SYSTEM MARKET, BY DEPLOYMENT MODE, 2018–2030 (USD MILLION)

TABLE 15 GLOBAL: PHARMACY MANAGEMENT SYSTEM MARKET FOR CLOUD/WEB-BASED, BY REGION, 2018–2030 (USD MILLION)

TABLE 16 GLOBAL: PHARMACY MANAGEMENT SYSTEM MARKET FOR ON-PREMISE, BY REGION, 2018–2030 (USD MILLION)

TABLE 17 GLOBAL: PHARMACY MANAGEMENT SYSTEM MARKET, BY END USER, 2018–2030 (USD MILLION)

TABLE 18 GLOBAL: PHARMACY MANAGEMENT SYSTEM MARKET FOR INPATIENT PHARMACIES, BY REGION, 2018–2030 (USD MILLION)

TABLE 19 GLOBAL: PHARMACY MANAGEMENT SYSTEM MARKET FOR INPATIENT PHARMACIES, BY TYPE, 2018–2030 (USD MILLION)

TABLE 20 GLOBAL: PHARMACY MANAGEMENT SYSTEM MARKET FOR OUTPATIENT PHARMACIES, BY REGION, 2018–2030 (USD MILLION)

TABLE 21 GLOBAL: PHARMACY MANAGEMENT SYSTEM MARKET FOR OUTPATIENT PHARMACIES, BY TYPE, 2018–2030 (USD MILLION)

TABLE 22 GLOBAL: PHARMACY MANAGEMENT SYSTEM MARKET, BY REGION, 2018–2030 (USD MILLION)

TABLE 23 AMERICAS: PHARMACY MANAGEMENT SYSTEM MARKET, BY COUNTRY, 2018–2030 (USD MILLION)

TABLE 24 AMERICAS: PHARMACY MANAGEMENT SYSTEM MARKET, BY SOLUTION TYPE, 2018–2030 (USD MILLION)

TABLE 25 AMERICAS: PHARMACY MANAGEMENT SYSTEM MARKET FOR SERVICES, BY COMPONENT, 2018–2030 (USD MILLION)

TABLE 26 AMERICAS: PHARMACY MANAGEMENT SYSTEM MARKET, BY DEPLOYMENT MODE, 2018–2030 (USD MILLION)

TABLE 27 AMERICAS: PHARMACY MANAGEMENT SYSTEM MARKET, BY END USER, 2018–2030 (USD MILLION)

TABLE 28 AMERICAS: PHARMACY MANAGEMENT SYSTEM MARKET FOR INPATIENT PHARMACIES, BY END USER, 2018–2030 (USD MILLION)

TABLE 29 AMERICAS: PHARMACY MANAGEMENT SYSTEM MARKET FOR OUTPATIENT PHARMACIES, BY END USER, 2018–2030 (USD MILLION)

TABLE 30 NORTH AMERICA: PHARMACY MANAGEMENT SYSTEM MARKET, BY COUNTRY, 2018–2030 (USD MILLION)

TABLE 31 NORTH AMERICA: PHARMACY MANAGEMENT SYSTEM MARKET, BY SOLUTION TYPE, 2018–2030 (USD MILLION)

TABLE 32 NORTH AMERICA: PHARMACY MANAGEMENT SYSTEM MARKET FOR SERVICES, BY COMPONENT, 2018–2030 (USD MILLION)

TABLE 33 NORTH AMERICA: PHARMACY MANAGEMENT SYSTEM MARKET, BY DEPLOYMENT MODE, 2018–2030 (USD MILLION)

TABLE 34 NORTH AMERICA: PHARMACY MANAGEMENT SYSTEM MARKET, BY END USER, 2018–2030 (USD MILLION)

TABLE 35 NORTH AMERICA: PHARMACY MANAGEMENT SYSTEM MARKET FOR INPATIENT PHARMACIES, BY END USER, 2018–2030 (USD MILLION)

TABLE 36 NORTH AMERICA: PHARMACY MANAGEMENT SYSTEM MARKET FOR OUTPATIENT PHARMACIES, BY END USER, 2018–2030 (USD MILLION)

TABLE 37 US: PHARMACY MANAGEMENT SYSTEM MARKET, BY SOLUTION TYPE, 2018–2030 (USD MILLION)

TABLE 38 US: PHARMACY MANAGEMENT SYSTEM MARKET FOR SERVICES, BY COMPONENT, 2018–2030 (USD MILLION)

TABLE 39 US: PHARMACY MANAGEMENT SYSTEM MARKET, BY DEPLOYMENT MODE, 2018–2030 (USD MILLION)

TABLE 40 US: PHARMACY MANAGEMENT SYSTEM MARKET, BY END USER, 2018–2030 (USD MILLION)

TABLE 41 US: PHARMACY MANAGEMENT SYSTEM MARKET FOR INPATIENT PHARMACIES, BY END USER, 2018–2030 (USD MILLION)

TABLE 42 US: PHARMACY MANAGEMENT SYSTEM MARKET FOR OUTPATIENT PHARMACIES, BY END USER, 2018–2030 (USD MILLION)

TABLE 43 CANADA: PHARMACY MANAGEMENT SYSTEM MARKET, BY SOLUTION TYPE, 2018–2030 (USD MILLION)

TABLE 44 CANADA: PHARMACY MANAGEMENT SYSTEM MARKET FOR SERVICES, BY COMPONENT, 2018–2030 (USD MILLION)

TABLE 45 CANADA: PHARMACY MANAGEMENT SYSTEM MARKET, BY DEPLOYMENT MODE, 2018–2030 (USD MILLION)

TABLE 46 CANADA: PHARMACY MANAGEMENT SYSTEM MARKET, BY END USER, 2018–2030 (USD MILLION)

TABLE 47 CANADA: PHARMACY MANAGEMENT SYSTEM MARKET FOR INPATIENT PHARMACIES, BY END USER, 2018–2030 (USD MILLION)

TABLE 48 CANADA: PHARMACY MANAGEMENT SYSTEM MARKET FOR OUTPATIENT PHARMACIES, BY END USER, 2018–2030 (USD MILLION)

TABLE 49 EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET, BY REGION, 2018–2030 (USD MILLION)

TABLE 50 EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET, BY SOLUTION TYPE, 2018–2030 (USD MILLION)

TABLE 51 EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET FOR SERVICES, BY COMPONENT, 2018–2030 (USD MILLION)

TABLE 52 EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET, BY DEPLOYMENT MODE, 2018–2030 (USD MILLION)

TABLE 53 EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET, BY END USER, 2018–2030 (USD MILLION)

TABLE 54 EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET FOR INPATIENT PHARMACIES, BY END USER, 2018–2030 (USD MILLION)

TABLE 55 EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET FOR OUTPATIENT PHARMACIES, BY END USER, 2018–2030 (USD MILLION)

TABLE 56 WESTERN EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET, BY COUNTRY, 2018–2030 (USD MILLION)

TABLE 57 WESTERN EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET, BY SOLUTION TYPE, 2018–2030 (USD MILLION)

TABLE 58 WESTERN EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET FOR SERVICES, BY COMPONENT, 2018–2030 (USD MILLION)

TABLE 59 WESTERN EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET, BY DEPLOYMENT MODE, 2018–2030 (USD MILLION)

TABLE 60 WESTERN EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET, BY END USER, 2018–2030 (USD MILLION)

TABLE 61 WESTERN EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET FOR INPATIENT PHARMACIES, BY END USER, 2018–2030 (USD MILLION)

TABLE 62 WESTERN EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET FOR OUTPATIENT PHARMACIES, BY END USER, 2018–2030 (USD MILLION)

TABLE 63 GERMANY: PHARMACY MANAGEMENT SYSTEM MARKET, BY SOLUTION TYPE, 2018–2030 (USD MILLION)

TABLE 64 GERMANY: PHARMACY MANAGEMENT SYSTEM MARKET FOR SERVICES, BY COMPONENT, 2018–2030 (USD MILLION)

TABLE 65 GERMANY: PHARMACY MANAGEMENT SYSTEM MARKET, BY DEPLOYMENT MODE, 2018–2030 (USD MILLION)

TABLE 66 GERMANY: PHARMACY MANAGEMENT SYSTEM MARKET, BY END USER, 2018–2030 (USD MILLION)

TABLE 67 GERMANY: PHARMACY MANAGEMENT SYSTEM MARKET FOR INPATIENT PHARMACIES, BY END USER, 2018–2030 (USD MILLION)

TABLE 68 GERMANY: PHARMACY MANAGEMENT SYSTEM MARKET FOR OUTPATIENT PHARMACIES, BY END USER, 2018–2030 (USD MILLION)

TABLE 69 FRANCE: PHARMACY MANAGEMENT SYSTEM MARKET, BY SOLUTION TYPE, 2018–2030 (USD MILLION)

TABLE 70 FRANCE: PHARMACY MANAGEMENT SYSTEM MARKET FOR SERVICES, BY COMPONENT, 2018–2030 (USD MILLION)

TABLE 71 FRANCE: PHARMACY MANAGEMENT SYSTEM MARKET, BY DEPLOYMENT MODE, 2018–2030 (USD MILLION)

TABLE 72 FRANCE: PHARMACY MANAGEMENT SYSTEM MARKET, BY END USER, 2018–2030 (USD MILLION)

TABLE 73 FRANCE: PHARMACY MANAGEMENT SYSTEM MARKET FOR INPATIENT PHARMACIES, BY END USER, 2018–2030 (USD MILLION)

TABLE 74 FRANCE: PHARMACY MANAGEMENT SYSTEM MARKET FOR OUTPATIENT PHARMACIES, BY END USER, 2018–2030 (USD MILLION)

TABLE 75 UK: PHARMACY MANAGEMENT SYSTEM MARKET, BY SOLUTION TYPE, 2018–2030 (USD MILLION)

TABLE 76 UK: PHARMACY MANAGEMENT SYSTEM MARKET FOR SERVICES, BY COMPONENT, 2018–2030 (USD MILLION)

TABLE 77 UK: PHARMACY MANAGEMENT SYSTEM MARKET, BY DEPLOYMENT MODE, 2018–2030 (USD MILLION)

TABLE 78 UK: PHARMACY MANAGEMENT SYSTEM MARKET, BY END USER, 2018–2030 (USD MILLION)

TABLE 79 UK: PHARMACY MANAGEMENT SYSTEM MARKET FOR INPATIENT PHARMACIES, BY END USER, 2018–2030 (USD MILLION)

TABLE 80 UK: PHARMACY MANAGEMENT SYSTEM MARKET FOR OUTPATIENT PHARMACIES, BY END USER, 2018–2030 (USD MILLION)

TABLE 81 ITALY: PHARMACY MANAGEMENT SYSTEM MARKET, BY SOLUTION TYPE, 2018–2030 (USD MILLION)

TABLE 82 ITALY: PHARMACY MANAGEMENT SYSTEM MARKET FOR SERVICES, BY COMPONENT, 2018–2030 (USD MILLION)

TABLE 83 ITALY: PHARMACY MANAGEMENT SYSTEM MARKET, BY DEPLOYMENT MODE, 2018–2030 (USD MILLION)

TABLE 84 ITALY: PHARMACY MANAGEMENT SYSTEM MARKET, BY END USER, 2018–2030 (USD MILLION)

TABLE 85 ITALY: PHARMACY MANAGEMENT SYSTEM MARKET FOR INPATIENT PHARMACIES, BY END USER, 2018–2030 (USD MILLION)

TABLE 86 ITALY: PHARMACY MANAGEMENT SYSTEM MARKET FOR OUTPATIENT PHARMACIES, BY END USER, 2018–2030 (USD MILLION)

TABLE 87 SPAIN: PHARMACY MANAGEMENT SYSTEM MARKET, BY SOLUTION TYPE, 2018–2030 (USD MILLION)

TABLE 88 SPAIN: PHARMACY MANAGEMENT SYSTEM MARKET FOR SERVICES, BY COMPONENT, 2018–2030 (USD MILLION)

TABLE 89 SPAIN: PHARMACY MANAGEMENT SYSTEM MARKET, BY DEPLOYMENT MODE, 2018–2030 (USD MILLION)

TABLE 90 SPAIN: PHARMACY MANAGEMENT SYSTEM MARKET, BY END USER, 2018–2030 (USD MILLION)

TABLE 91 SPAIN: PHARMACY MANAGEMENT SYSTEM MARKET FOR INPATIENT PHARMACIES, BY END USER, 2018–2030 (USD MILLION)

TABLE 92 SPAIN: PHARMACY MANAGEMENT SYSTEM MARKET FOR OUTPATIENT PHARMACIES, BY END USER, 2018–2030 (USD MILLION)

TABLE 93 NETHERLANDS: PHARMACY MANAGEMENT SYSTEM MARKET, BY SOLUTION TYPE, 2018–2030 (USD MILLION)

TABLE 94 NETHERLANDS: PHARMACY MANAGEMENT SYSTEM MARKET FOR SERVICES, BY COMPONENT, 2018–2030 (USD MILLION)

TABLE 95 NETHERLANDS: PHARMACY MANAGEMENT SYSTEM MARKET, BY DEPLOYMENT MODE, 2018–2030 (USD MILLION)

TABLE 96 NETHERLANDS: PHARMACY MANAGEMENT SYSTEM MARKET, BY END USER, 2018–2030 (USD MILLION)

TABLE 97 NETHERLANDS: PHARMACY MANAGEMENT SYSTEM MARKET FOR INPATIENT PHARMACIES, BY END USER, 2018–2030 (USD MILLION)

TABLE 98 NETHERLANDS: PHARMACY MANAGEMENT SYSTEM MARKET FOR OUTPATIENT PHARMACIES, BY END USER, 2018–2030 (USD MILLION)

TABLE 99 SWITZERLAND: PHARMACY MANAGEMENT SYSTEM MARKET, BY SOLUTION TYPE, 2018–2030 (USD MILLION)

TABLE 100 SWITZERLAND: PHARMACY MANAGEMENT SYSTEM MARKET FOR SERVICES, BY COMPONENT, 2018–2030 (USD MILLION)

TABLE 101 SWITZERLAND: PHARMACY MANAGEMENT SYSTEM MARKET, BY DEPLOYMENT MODE, 2018–2030 (USD MILLION)

TABLE 102 SWITZERLAND: PHARMACY MANAGEMENT SYSTEM MARKET, BY END USER, 2018–2030 (USD MILLION)

TABLE 103 SWITZERLAND: PHARMACY MANAGEMENT SYSTEM MARKET FOR INPATIENT PHARMACIES, BY END USER, 2018–2030 (USD MILLION)

TABLE 104 SWITZERLAND: PHARMACY MANAGEMENT SYSTEM MARKET FOR OUTPATIENT PHARMACIES, BY END USER, 2018–2030 (USD MILLION)

TABLE 105 BELGIUM: PHARMACY MANAGEMENT SYSTEM MARKET, BY SOLUTION TYPE, 2018–2030 (USD MILLION)

TABLE 106 BELGIUM: PHARMACY MANAGEMENT SYSTEM MARKET FOR SERVICES, BY COMPONENT, 2018–2030 (USD MILLION)

TABLE 107 BELGIUM: PHARMACY MANAGEMENT SYSTEM MARKET, BY DEPLOYMENT MODE, 2018–2030 (USD MILLION)

TABLE 108 BELGIUM: PHARMACY MANAGEMENT SYSTEM MARKET, BY END USER, 2018–2030 (USD MILLION)

TABLE 109 BELGIUM: PHARMACY MANAGEMENT SYSTEM MARKET FOR INPATIENT PHARMACIES, BY END USER, 2018–2030 (USD MILLION)

TABLE 110 BELGIUM: PHARMACY MANAGEMENT SYSTEM MARKET FOR OUTPATIENT PHARMACIES, BY END USER, 2018–2030 (USD MILLION)

TABLE 111 AUSTRIA: PHARMACY MANAGEMENT SYSTEM MARKET, BY SOLUTION TYPE, 2018–2030 (USD MILLION)

TABLE 112 AUSTRIA: PHARMACY MANAGEMENT SYSTEM MARKET FOR SERVICES, BY COMPONENT, 2018–2030 (USD MILLION)

TABLE 113 AUSTRIA: PHARMACY MANAGEMENT SYSTEM MARKET, BY DEPLOYMENT MODE, 2018–2030 (USD MILLION)

TABLE 114 AUSTRIA: PHARMACY MANAGEMENT SYSTEM MARKET, BY END USER, 2018–2030 (USD MILLION)

TABLE 115 AUSTRIA: PHARMACY MANAGEMENT SYSTEM MARKET FOR INPATIENT PHARMACIES, BY END USER, 2018–2030 (USD MILLION)

TABLE 116 AUSTRIA: PHARMACY MANAGEMENT SYSTEM MARKET FOR OUTPATIENT PHARMACIES, BY END USER, 2018–2030 (USD MILLION)

TABLE 117 REST OF WESTERN EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET, BY SOLUTION TYPE, 2018–2030 (USD MILLION)

TABLE 118 REST OF WESTERN EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET FOR SERVICES, BY COMPONENT, 2018–2030 (USD MILLION)

TABLE 119 REST OF WESTERN EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET, BY DEPLOYMENT MODE, 2018–2030 (USD MILLION)

TABLE 120 REST OF WESTERN EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET, BY END USER, 2018–2030 (USD MILLION)

TABLE 121 REST OF WESTERN EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET FOR INPATIENT PHARMACIES, BY END USER, 2018–2030 (USD MILLION)

TABLE 122 REST OF WESTERN EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET FOR OUTPATIENT PHARMACIES, BY END USER, 2018–2030 (USD MILLION)

TABLE 123 EASTERN EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET, BY SOLUTION TYPE, 2018–2030 (USD MILLION)

TABLE 124 EASTERN EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET FOR SERVICES, BY COMPONENT, 2018–2030 (USD MILLION)

TABLE 125 EASTERN EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET, BY DEPLOYMENT MODE, 2018–2030 (USD MILLION)

TABLE 126 EASTERN EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET, BY END USER, 2018–2030 (USD MILLION)

TABLE 127 EASTERN EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET FOR INPATIENT PHARMACIES, BY END USER, 2018–2030 (USD MILLION)

TABLE 128 EASTERN EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET FOR OUTPATIENT PHARMACIES, BY END USER, 2018–2030 (USD MILLION)

TABLE 129 ASIA-PACIFIC: PHARMACY MANAGEMENT SYSTEMS, BY COUNTRY, 2018–2030 (USD MILLION)

TABLE 130 ASIA-PACIFIC: PHARMACY MANAGEMENT SYSTEMS, BY SOLUTION TYPE, 2018–2030 (USD MILLION)

TABLE 131 ASIA-PACIFIC: PHARMACY MANAGEMENT SYSTEMS, BY COMPONENT, 2018–2030 (USD MILLION)

TABLE 132 ASIA-PACIFIC: PHARMACY MANAGEMENT SYSTEMS, BY DEPLOYMENT MODE, 2018–2030 (USD MILLION)

TABLE 133 ASIA-PACIFIC: PHARMACY MANAGEMENT SYSTEMS, BY END USER, 2018–2030 (USD MILLION)

TABLE 134 ASIA-PACIFIC: PHARMACY MANAGEMENT SYSTEMS, BY INPATIENT PHARMACIES, 2018–2030 (USD MILLION)

TABLE 135 ASIA-PACIFIC: PHARMACY MANAGEMENT SYSTEMS, BY OUTPATIENT PHARMACIES, 2018–2030 (USD MILLION)

TABLE 136 JAPAN: PHARMACY MANAGEMENT SYSTEMS, BY SOLUTION TYPE, 2018–2030 (USD MILLION)

TABLE 137 JAPAN: PHARMACY MANAGEMENT SYSTEMS, BY COMPONENT, 2018–2030 (USD MILLION)

TABLE 138 JAPAN: PHARMACY MANAGEMENT SYSTEMS, BY DEPLOYMENT MODE, 2018–2030 (USD MILLION)

TABLE 139 JAPAN: PHARMACY MANAGEMENT SYSTEMS, BY END USER, 2018–2030 (USD MILLION)

TABLE 140 JAPAN: PHARMACY MANAGEMENT SYSTEMS, BY INPATIENT PHARMACIES, 2018–2030 (USD MILLION)

TABLE 141 JAPAN: PHARMACY MANAGEMENT SYSTEMS, BY OUTPATIENT PHARMACIES, 2018–2030 (USD MILLION)

TABLE 142 CHINA: PHARMACY MANAGEMENT SYSTEMS, BY SOLUTION TYPE, 2018–2030 (USD MILLION)

TABLE 143 CHINA: PHARMACY MANAGEMENT SYSTEMS, BY COMPONENT, 2018–2030 (USD MILLION)

TABLE 144 CHINA: PHARMACY MANAGEMENT SYSTEMS, BY DEPLOYMENT MODE, 2018–2030 (USD MILLION)

TABLE 145 CHINA: PHARMACY MANAGEMENT SYSTEMS, BY END USER, 2018–2030 (USD MILLION)

TABLE 146 CHINA: PHARMACY MANAGEMENT SYSTEMS, BY INPATIENT PHARMACIES, 2018–2030 (USD MILLION)

TABLE 147 CHINA: PHARMACY MANAGEMENT SYSTEMS, BY OUTPATIENT PHARMACIES, 2018–2030 (USD MILLION)

TABLE 148 INDIA: PHARMACY MANAGEMENT SYSTEMS, BY SOLUTION TYPE, 2018–2030 (USD MILLION)

TABLE 149 INDIA: PHARMACY MANAGEMENT SYSTEMS, BY COMPONENT, 2018–2030 (USD MILLION)

TABLE 150 INDIA: PHARMACY MANAGEMENT SYSTEMS, BY DEPLOYMENT MODE, 2018–2030 (USD MILLION)

TABLE 151 INDIA: PHARMACY MANAGEMENT SYSTEMS, BY END USER, 2018–2030 (USD MILLION)

TABLE 152 INDIA: PHARMACY MANAGEMENT SYSTEMS, BY INPATIENT PHARMACIES, 2018–2030 (USD MILLION)

TABLE 153 INDIA: PHARMACY MANAGEMENT SYSTEMS, BY OUTPATIENT PHARMACIES, 2018–2030 (USD MILLION)

TABLE 154 AUSTRALIA: PHARMACY MANAGEMENT SYSTEMS, BY SOLUTION TYPE, 2018–2030 (USD MILLION)

TABLE 155 AUSTRALIA: PHARMACY MANAGEMENT SYSTEMS, BY COMPONENT, 2018–2030 (USD MILLION)

TABLE 156 AUSTRALIA: PHARMACY MANAGEMENT SYSTEMS, BY DEPLOYMENT MODE, 2018–2030 (USD MILLION)

TABLE 157 AUSTRALIA: PHARMACY MANAGEMENT SYSTEMS, BY END USER, 2018–2030 (USD MILLION)

TABLE 158 AUSTRALIA: PHARMACY MANAGEMENT SYSTEMS, BY INPATIENT PHARMACIES, 2018–2030 (USD MILLION)

TABLE 159 AUSTRALIA: PHARMACY MANAGEMENT SYSTEMS, BY OUTPATIENT PHARMACIES, 2018–2030 (USD MILLION)

TABLE 160 SOUTH KOREA: PHARMACY MANAGEMENT SYSTEMS, BY SOLUTION TYPE, 2018–2030 (USD MILLION)

TABLE 161 SOUTH KOREA: PHARMACY MANAGEMENT SYSTEMS, BY COMPONENT, 2018–2030 (USD MILLION)

TABLE 162 SOUTH KOREA: PHARMACY MANAGEMENT SYSTEMS, BY DEPLOYMENT MODE, 2018–2030 (USD MILLION)

TABLE 163 SOUTH KOREA: PHARMACY MANAGEMENT SYSTEMS, BY END USER, 2018–2030 (USD MILLION)

TABLE 164 SOUTH KOREA: PHARMACY MANAGEMENT SYSTEMS, BY INPATIENT PHARMACIES, 2018–2030 (USD MILLION)

TABLE 165 SOUTH KOREA: PHARMACY MANAGEMENT SYSTEMS, BY OUTPATIENT PHARMACIES, 2018–2030 (USD MILLION)

TABLE 166 TAIWAN: PHARMACY MANAGEMENT SYSTEMS, BY SOLUTION TYPE, 2018–2030 (USD MILLION)

TABLE 167 TAIWAN: PHARMACY MANAGEMENT SYSTEMS, BY COMPONENT, 2018–2030 (USD MILLION)

TABLE 168 TAIWAN: PHARMACY MANAGEMENT SYSTEMS, BY DEPLOYMENT MODE, 2018–2030 (USD MILLION)

TABLE 169 TAIWAN: PHARMACY MANAGEMENT SYSTEMS, BY END USER, 2018–2030 (USD MILLION)

TABLE 170 TAIWAN: PHARMACY MANAGEMENT SYSTEMS, BY INPATIENT PHARMACIES, 2018–2030 (USD MILLION)

TABLE 171 TAIWAN: PHARMACY MANAGEMENT SYSTEMS, BY OUTPATIENT PHARMACIES, 2018–2030 (USD MILLION)

TABLE 172 NEW ZEALAND: PHARMACY MANAGEMENT SYSTEMS, BY SOLUTION TYPE, 2018–2030 (USD MILLION)

TABLE 173 NEW ZEALAND: PHARMACY MANAGEMENT SYSTEMS, BY COMPONENT, 2018–2030 (USD MILLION)

TABLE 174 NEW ZEALAND: PHARMACY MANAGEMENT SYSTEMS, BY DEPLOYMENT MODE, 2018–2030 (USD MILLION)

TABLE 175 NEW ZEALAND: PHARMACY MANAGEMENT SYSTEMS, BY END USER, 2018–2030 (USD MILLION)

TABLE 176 NEW ZEALAND: PHARMACY MANAGEMENT SYSTEMS, BY INPATIENT PHARMACIES, 2018–2030 (USD MILLION)

TABLE 177 NEW ZEALAND: PHARMACY MANAGEMENT SYSTEMS, BY OUTPATIENT PHARMACIES, 2018–2030 (USD MILLION)

TABLE 178 THAILAND: PHARMACY MANAGEMENT SYSTEMS, BY SOLUTION TYPE, 2018–2030 (USD MILLION)

TABLE 179 THAILAND: PHARMACY MANAGEMENT SYSTEMS, BY COMPONENT, 2018–2030 (USD MILLION)

TABLE 180 THAILAND: PHARMACY MANAGEMENT SYSTEMS, BY DEPLOYMENT MODE, 2018–2030 (USD MILLION)

TABLE 181 THAILAND: PHARMACY MANAGEMENT SYSTEMS, BY END USER, 2018–2030 (USD MILLION)

TABLE 182 THAILAND: PHARMACY MANAGEMENT SYSTEMS, BY INPATIENT PHARMACIES, 2018–2030 (USD MILLION)

TABLE 183 THAILAND: PHARMACY MANAGEMENT SYSTEMS, BY OUTPATIENT PHARMACIES, 2018–2030 (USD MILLION)

TABLE 184 PHILIPPINES: PHARMACY MANAGEMENT SYSTEMS, BY SOLUTION TYPE, 2018–2030 (USD MILLION)

TABLE 185 PHILIPPINES: PHARMACY MANAGEMENT SYSTEMS, BY COMPONENT, 2018–2030 (USD MILLION)

TABLE 186 PHILIPPINES: PHARMACY MANAGEMENT SYSTEMS, BY DEPLOYMENT MODE, 2018–2030 (USD MILLION)

TABLE 187 PHILIPPINES: PHARMACY MANAGEMENT SYSTEMS, BY END USER, 2018–2030 (USD MILLION)

TABLE 188 PHILIPPINES: PHARMACY MANAGEMENT SYSTEMS, BY INPATIENT PHARMACIES, 2018–2030 (USD MILLION)

TABLE 189 PHILIPPINES: PHARMACY MANAGEMENT SYSTEMS, BY OUTPATIENT PHARMACIES, 2018–2030 (USD MILLION)

TABLE 190 REST OF ASIA-PACIFIC: PHARMACY MANAGEMENT SYSTEMS, BY SOLUTION TYPE, 2018–2030 (USD MILLION)

TABLE 191 REST OF ASIA-PACIFIC: PHARMACY MANAGEMENT SYSTEMS, BY COMPONENT, 2018–2030 (USD MILLION)

TABLE 192 REST OF ASIA-PACIFIC: PHARMACY MANAGEMENT SYSTEMS, BY DEPLOYMENT MODE, 2018–2030 (USD MILLION)

TABLE 193 REST OF ASIA-PACIFIC: PHARMACY MANAGEMENT SYSTEMS, BY END USER, 2018–2030 (USD MILLION)

TABLE 194 REST OF ASIA-PACIFIC: PHARMACY MANAGEMENT SYSTEMS, BY INPATIENT PHARMACIES, 2018–2030 (USD MILLION)

TABLE 195 REST OF ASIA-PACIFIC: PHARMACY MANAGEMENT SYSTEMS, BY OUTPATIENT PHARMACIES, 2018–2030 (USD MILLION)

TABLE 196 MIDDLE EAST & AFRICA: PHARMACY MANAGEMENT SYSTEMS, BY COUNTRY, 2018–2030 (USD MILLION)

TABLE 197 MIDDLE EAST & AFRICA: PHARMACY MANAGEMENT SYSTEMS, BY SOLUTION TYPE, 2018–2030 (USD MILLION)

TABLE 198 MIDDLE EAST & AFRICA: PHARMACY MANAGEMENT SYSTEMS, BY COMPONENT, 2018–2030 (USD MILLION)

TABLE 199 MIDDLE EAST & AFRICA: PHARMACY MANAGEMENT SYSTEMS, BY DEPLOYMENT MODE, 2018–2030 (USD MILLION)

TABLE 200 MIDDLE EAST & AFRICA: PHARMACY MANAGEMENT SYSTEMS, BY END USER, 2018–2030 (USD MILLION)

TABLE 201 MIDDLE EAST & AFRICA: PHARMACY MANAGEMENT SYSTEMS, BY INPATIENT PHARMACIES, 2018–2030 (USD MILLION)

TABLE 202 MIDDLE EAST & AFRICA: PHARMACY MANAGEMENT SYSTEMS, BY OUTPATIENT PHARMACIES, 2018–2030 (USD MILLION)

TABLE 203 MIDDLE EAST: PHARMACY MANAGEMENT SYSTEMS, BY SOLUTION TYPE, 2018–2030 (USD MILLION)

TABLE 204 MIDDLE EAST: PHARMACY MANAGEMENT SYSTEMS, BY COMPONENT, 2018–2030 (USD MILLION)

TABLE 205 MIDDLE EAST: PHARMACY MANAGEMENT SYSTEMS, BY DEPLOYMENT MODE, 2018–2030 (USD MILLION)

TABLE 206 MIDDLE EAST: PHARMACY MANAGEMENT SYSTEMS, BY END USER, 2018–2030 (USD MILLION)

TABLE 207 MIDDLE EAST: PHARMACY MANAGEMENT SYSTEMS, BY INPATIENT PHARMACIES, 2018–2030 (USD MILLION)

TABLE 208 MIDDLE EAST: PHARMACY MANAGEMENT SYSTEMS, BY OUTPATIENT PHARMACIES, 2018–2030 (USD MILLION)

TABLE 209 AFRICA: PHARMACY MANAGEMENT SYSTEMS, BY SOLUTION TYPE, 2018–2030 (USD MILLION)

TABLE 210 AFRICA: PHARMACY MANAGEMENT SYSTEMS, BY COMPONENT, 2018–2030 (USD MILLION)

TABLE 211 AFRICA: PHARMACY MANAGEMENT SYSTEMS, BY DEPLOYMENT MODE, 2018–2030 (USD MILLION)

TABLE 212 AFRICA: PHARMACY MANAGEMENT SYSTEMS, BY END USER, 2018–2030 (USD MILLION)

TABLE 213 AFRICA: PHARMACY MANAGEMENT SYSTEMS, BY INPATIENT PHARMACIES, 2018–2030 (USD MILLION)

TABLE 214 AFRICA: PHARMACY MANAGEMENT SYSTEMS, BY OUTPATIENT PHARMACIES, 2018–2030 (USD MILLION)

TABLE 215 MAJOR PLAYERS IN THE GLOBAL PHARMACY MANAGEMENT SYSTEM MARKET

TABLE 216 MOST ACTIVE PLAYERS IN THE GLOBAL PHARMACY MANAGEMENT SYSTEM MARKET

TABLE 217 PRODUCT LAUNCH/PRODUCT APPROVAL

TABLE 218 MERGER & ACQUISITIONS

TABLE 219 AGREEMENT/MARKETING STRATEGIES

TABLE 220 ALLSCRIPTS HEALTHCARE, LLC: SERVICES OFFERED

TABLE 221 ALLSCRIPTS HEALTHCARE, LLC: KEY DEVELOPMENTS

TABLE 222 CERNER CORPORATION: PRODUCTS OFFERED

TABLE 223 DATASCAN PHARMACY: PRODUCTS OFFERED

TABLE 224 EPICOR SOFTWARE CORPORATION: PRODUCTS OFFERED

TABLE 225 GLOBEMED GROUP: PRODUCTS OFFERED

TABLE 226 LIBERTY SOFTWARE, INC.: PRODUCTS OFFERED

TABLE 227 LS RETAIL EHF.: PRODUCTS OFFERED

TABLE 228 MCKESSON CORPORATION: PRODUCTS OFFERED

TABLE 229 MCKESSON CORPORATION: KEY DEVELOPMENTS

TABLE 230 MEDHOK, INC.: PRODUCTS OFFERED

TABLE 231 OCTAL IT SOLUTION LLP.: PRODUCTS OFFERED

TABLE 232 SAFECARE TECHNOLOGY: PRODUCTS OFFERED

TABLE 233 SCRIPTPRO LLC: PRODUCTS OFFERED

TABLE 234 CLANWILLIAM HEALTH: PRODUCTS OFFERED

TABLE 235 CLANWILLIAM HEALTH: KEY DEVELOPMENTS

TABLE 236 MOBILE MEDSOFT: PRODUCTS OFFERED

TABLE 237 HEALTHCARE BUSINESS SYSTEMS, INC.: PRODUCTS OFFERED

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 薬局管理システムの世界市場（〜2030）(Pharmacy Management System Market Forecast to 2030)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

薬局管理システムの世界市場（〜2030）

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp